INTERACTION OF ADENOVIRAL E4 AND E1B PRODUCTS IN LATE GENE-EXPRESSION

被引:118
|
作者
BRIDGE, E
KETNER, G
机构
[1] JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT IMMUNOL & INFECT DIS,615 N WOLFE ST,BALTIMORE,MD 21205
[2] JOHNS HOPKINS UNIV,DEPT BIOL,BALTIMORE,MD 21218
基金
美国国家科学基金会;
关键词
D O I
10.1016/0042-6822(90)90088-9
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The adenovirus 294R protein of E4 ORF 6 forms a physical and functional complex with the 496R protein product of E1b. The E4 294R ORF 6 protein also functions in parallel with the E4 116R ORF 3 protein in viral late protein synthesis. We have examined the roles of these three proteins and the protein complex in viral late protein synthesis and late message metabolism, by comparing the phenotypes of E4 294R-, E4 116R-, and E1b 496R- mutants to those of a series of double mutants. Our data indicate that the 294R and 116R proteins act in parallel to permit the accumulation of normal levels of unprocessed late viral RNA in the nucleus of infected cells. Both 294R and 496R function in parallel with the 116R protein in viral nuclear RNA accumulation, but do so to different degrees, suggesting that 294R and 496R may have roles apart from the functional complex in mediating accumulation of viral messages in the nucleus, or that they have nonequivalent roles within the complex. Our results are also consistent with a role for the 496R/294R protein complex in mediating efficient transport of late messages from the nucleus to the cytoplasm and/or in maintaining the stability of those messages on reaching the cytoplasm, as suggested previously S. Pilder, M. Moore, J. Logan, and T. Shenk, 1986, Mol. Cell. Biol. 6, 470-476). Finally the 116R protein seems to act in parallel with the complex to permit normal viral DNA replication. © 1990.
引用
收藏
页码:345 / 353
页数:9
相关论文
共 50 条
  • [31] AUTOREGULATION OF ADENOVIRUS-E1A GENE-EXPRESSION
    TIBBETTS, C
    LARSEN, PL
    JONES, SN
    [J]. JOURNAL OF VIROLOGY, 1986, 57 (03) : 1055 - 1064
  • [32] Expression of the bovine papillomavirus type 1 E5B gene reveals a protein-protein interaction of the E5A and E5B gene products
    Wlazlo, AP
    Sparkowski, JJ
    Jenson, AB
    Schlegel, R
    [J]. VIROLOGY, 2003, 307 (02) : 396 - 405
  • [33] Regulation of apoptosis by adenovirus E1A and E1B oncogenes
    White, E
    [J]. SEMINARS IN VIROLOGY, 1998, 8 (06): : 505 - 513
  • [34] Leukotriene E4 regulates gene expression in human mast cells
    Foster, H. R.
    Fuerst, E.
    Lee, T. H.
    Woszczek, G.
    [J]. ALLERGY, 2013, 68 : 498 - 498
  • [35] REPRESSION OF PARATHYROID HORMONE-RELATED PROTEIN (PTHRP) GENE-EXPRESSION BY THE ADENOVIRAL E1A ONCOGENE
    FOLEY, J
    BROADUS, AE
    PHILBRICK, WM
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1995, 6 : 2012 - 2012
  • [36] Dissecting the roles of E1A and E1B in adenoviral replication and RCAd-enhanced RDAd transduction efficacy on tumor cells
    Wei, Fang
    Wang, Huiping
    Chen, Xiafang
    Li, Chuanyuan
    Huang, Qian
    [J]. CANCER BIOLOGY & THERAPY, 2014, 15 (10) : 1358 - 1366
  • [37] Adenovirus E4 34k and E1b 55k oncoproteins target host DNA ligase IV for proteasomal degradation
    Baker, Amy
    Rohleder, Kent J.
    Hanakahi, Les A.
    Ketner, Gary
    [J]. JOURNAL OF VIROLOGY, 2007, 81 (13) : 7034 - 7040
  • [38] Differential influence of the E4 adenoviral genes on viral and cellular promoters
    Grave, L
    Dreyer, D
    Dieterle, A
    Leroy, P
    Michou, AI
    Doderer, C
    Pavirani, A
    Lusky, M
    Mehtali, M
    [J]. JOURNAL OF GENE MEDICINE, 2000, 2 (06): : 433 - 443
  • [39] E1A, E1B double-restricted adenovirus for oncolytic gene therapy of gallbladder cancer
    Fukuda, K
    Abei, M
    Ugai, H
    Seo, E
    Wakayama, M
    Murata, T
    Todoroki, T
    Tanaka, N
    Hamada, H
    Yokoyama, KK
    [J]. CANCER RESEARCH, 2003, 63 (15) : 4434 - 4440
  • [40] Assessment of transgene expression and adenoviral vector growth following insertion of expression cassettes between the RITR and the E4 region of various adenoviral backbones
    Elahi, SM
    Nazemi-Moghaddam, N
    Bouthillier, F
    Oualikene, W
    Massie, B
    [J]. MOLECULAR THERAPY, 2003, 7 (05) : S61 - S61